Reprint

Down Syndrome

Neuropsychological Phenotype across the Lifespan

Edited by
May 2022
180 pages
  • ISBN978-3-0365-3962-1 (Hardback)
  • ISBN978-3-0365-3961-4 (PDF)

This book is a reprint of the Special Issue Down Syndrome: Neuropsychological Phenotype across the Lifespan that was published in

Biology & Life Sciences
Computer Science & Mathematics
Medicine & Pharmacology
Public Health & Healthcare
Summary

Down syndrome (DS), caused by the triplication of chromosome 21, is the most common genetic cause of intellectual disability (ID). Individuals with DS commonly exhibit unique neuropsychological profiles that emerge during specific developmental stages across the lifespan, often characterized by early developmental delay, cognitive strengths and weaknesses, behavior and mental health issues, and age-related cognitive decline, frequently resulting in early-onset Alzheimer’s disease. These profiles are unique compared to other individuals with ID and reflect the genetic mechanisms and neuroanatomic features underlying the distinct neuropsychological phenotype associated with DS. This Special Issue aims to highlight the recent advancements in understanding the neuropsychological phenotype associated with DS across the lifespan. The lifespan perspective will cover four developmental stages: (1) early childhood; (2) school age; (3) young adulthood, and (4) older adulthood. Authors contributed cutting-edge original research studies and comprehensive reviews that address a broad range of topics related to DS, including early developmental trajectories, cognitive functioning, language, adaptive skills, behavior and mental health, assessment and diagnosis, age-related cognitive decline, and medical issues related to the neuropsychological phenotype and neuroimaging.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
trisomy 21; decoding; vocabulary; letters; phonological awareness; down syndrome; fluency; disfluency; co-occurrence; comorbidity; language; Down syndrome; social cognition; social behavior; measurement; children; attention; audiovisual processing; Down syndrome; communicative abilities in infants; Trisomy 21; Down syndrome; independence; transition to adulthood; proxy-report; down syndrome; regression; Alzheimer’s disease; biomarkers; Down syndrome; dementia; cognition; functional independence; neuropsychological assessment; primary care; screening; Down syndrome; early regression; idiopathic regression; Down syndrome; depression; selective serotonin reuptake inhibitor; mild cognitive impairment; Alzheimer’s disease; Down syndrome; cognitive decline; neuropsychological tests; cognitive function; Down syndrome; early-onset Alzheimer disease; late-onset Alzheimer disease; hypothyroidism; thyroid autoantibodies; TSH; Free T4; APOE Ɛ4; Down syndrome; autism spectrum disorder; co-occurring; prevalence; n/a